SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001387131-17-001434
Filing Date
2017-03-16
Accepted
2017-03-16 18:35:59
Documents
2
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT moss-form3_022817.html 3  
1 OWNERSHIP DOCUMENT moss-form3_022817.xml 3 1656
2 POWER OF ATTORNEY ex24.htm EX-24 7909
  Complete submission text file 0001387131-17-001434.txt   11048
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11682 EL CAMINO REAL STE 300 SAN DIEGO CA 92130
Business Address
Moss Ronald B. (Reporting) CIK: 0001700786 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36242 | Film No.: 17695955